NEXTCURE INC. - COMMON STOCK

NextCure Provides Business Update and Reports First Quarter 2025 Financial Results

01 مايو 2025 16:05:00 بحسب Nasdaq GlobeNewswire

NextCure to Present at 24th Annual Needham Virtual Healthcare Conference

04 أبريل 2025 07:00:00 بحسب Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports Full Year 2024 Financial Results

06 مارس 2025 16:05:00 بحسب Nasdaq GlobeNewswire

NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers

10 يناير 2025 08:05:00 بحسب Nasdaq GlobeNewswire

NextCure Announces Acceptance of IND Application for LNCB74

10 ديسمبر 2024 08:05:00 بحسب Nasdaq GlobeNewswire

NextCure to Participate in the 36th Annual Piper Sandler Healthcare Conference

26 نوفمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta

19 نوفمبر 2024 08:05:00 بحسب Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results

07 نوفمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

NextCure Reports Preclinical Data for LNCB74 and Additional Clinical Biomarker Data for NC410 Combo at Society for Immunotherapy of Cancer Annual Meeting

05 نوفمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting

04 أكتوبر 2024 09:05:00 بحسب Nasdaq GlobeNewswire

NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024

16 سبتمبر 2024 08:05:00 بحسب Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results

01 أغسطس 2024 16:05:00 بحسب Nasdaq GlobeNewswire

NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

20 يونيو 2024 16:10:00 بحسب Nasdaq GlobeNewswire

NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024

30 مايو 2024 16:05:00 بحسب Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports First Quarter 2024 Financial Results

02 مايو 2024 16:05:00 بحسب Nasdaq GlobeNewswire

NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024

24 أبريل 2024 16:05:00 بحسب Nasdaq GlobeNewswire

NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024

08 أبريل 2024 07:00:00 بحسب Nasdaq GlobeNewswire

NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board

04 أبريل 2024 07:05:00 بحسب Nasdaq GlobeNewswire

NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference

02 أبريل 2024 07:00:00 بحسب Nasdaq GlobeNewswire

NextCure Provides Business Update and Reports Full Year 2023 Financial Results

21 مارس 2024 08:55:00 بحسب Nasdaq GlobeNewswire